News & Updates

First-line treatment with tislelizumab + chemotherapy significantly improves overall survival (OS) in patients with advanced or metastatic oesophageal squamous cell carcinoma (ESCC) compared with chemotherapy alone, according to an interim analysis of the RATIONALE-306* trial presented at ESMO GI 2022.

Women who use taxane chemotherapy agents are likely to experience epiphora, cystoid macular edema, and optic neuropathy, as reported in a retrospective cohort study.

Patients with oesophageal squamous cell carcinoma (ESCC) see better survival and safety outcomes after treatment with neoadjuvant chemoradiation therapy (NCRT) as compared with neoadjuvant chemotherapy (NCT) alone, according to a recent meta-analysis.

In the management of acute severe pain in older patients in the emergency department, hydromorphone provides only nonclinically significant greater effect than acetaminophen, with pain relief being minimal or incomplete regardless of the medication received, according to a study.

In some patients with osteoarticular infections (OAIs), an exclusively oral administration of antibiotics is safe and feasible, suggests a study.

The incidence of myocarditis and myocardial damage is higher than expected in cancer patients receiving immune checkpoint inhibitor (ICI) treatment, reports a recent real-world study.